BioHealth News Archive
AstraZeneca chief calls for global cooperation in the fight against COVID-19 and climate change – I by IMD
The chief executive of AstraZeneca has underscored the importance of multilateral cooperation in the fight against COVID-19 as well as other systemic global challenges…
Read More
Paul Rennie OBE and Professor Jason Snape Join Rich Bendis on BioTalk
Paul Rennie OBE, Counsellor for Global Issues in the Global Economy Group at the British Embassy, Washington DC, and Professor Jason Snape, Head of…
Read More
BHI EIR Feedback Day August 18th. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read More
MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market
GAITHERSBURG, Md., July 29, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the pricing of…
Read MoreEmergent BioSolutions to restart COVID-19 vaccine manufacturing in Baltimore – Technical.ly Baltimore
Maryland biotech company Emergent BioSolutions said on Thursday that it was approved by the U.S. Food and Drug Administration (FDA) to resume manufacturing of…
Read More
Shuttle Pharma Awarded a New Patent for Selective Inhibitors for Cancer Treatment
ROCKVILLE, Md., July 29, 2021 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc (Shuttle Pharma), a Maryland-based developer of new drugs for cancer treatment, was awarded…
Read More
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility · BioBuzz
GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview manufacturing facility to resume…
Read More
The Storied 25 Year History Behind the Baltimore Biotech Manufacturing Facility Producing COVID-19 Vaccines · BioBuzz
Emergent Biosolutions’ vaccine manufacturing plant in Baltimore has been the subject of many headlines this past year for its’ role in producing several COVID-19…
Read More
Boston Properties to Acquire Maryland Biotech Campus for $117M – Commercial Observer
Boston Properties (BXP) is set to acquire the Shady Grove Bio+Tech Campus, a seven-building, 435,000-square-foot office park in Rockville, Md., for $116.5 million, from…
Read More
The Delta Variant: How Companies Should Respond
The rapidly spreading Delta variant is forcing employers to rethink their strategies for handling the pandemic. Policies they should reconsider include encouraging or requiring…
Read More
Why is the delta variant of Covid-19 more transmissible? — Quartz India
The delta variant spreads much faster than other Covid-19 strains—and scientists may now know why. People infected with the delta variant have more than…
Read More
Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn’s Disease Patients
ROCKVILLE, Md. and CHESTERBROOK, Pa., July 26, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in…
Read More
Check-out JLABS quarterly portfolio update
Each quarter we bring you an update from our Johnson & Johnson Innovation – JLABS Portfolio of ompanies across our 13 sites, from San Diego…
Read More
Immunomic Therapeutics Expands Board of Directors with Appointments of Two New Members – Immunomic Therapeutics
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that it…
Read MoreMason’s Michael Buschmann and team at start-up AexeRNA Therapeutics Inc. pursue patents for improved COVID-19 vaccines
George Mason University bioengineering professor Michael Buschmann and a team of scientific collaborators have devised improved lipid nanoparticle technologies to deliver mRNA that could…
Read More